Navigation Links
Respiratory Leaders Urge Medical Community to Educate Patients Transitioning CFC to HFA Inhalers
Date:11/10/2008

At Year's End, Inhalers Used by 40 Million Patients Will No Longer Be Sold

SEATTLE, Nov. 10 /PRNewswire-USNewswire/ -- In less than 3 months, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold. After December 31, 2008, it will no longer be permissible to manufacture or sell albuterol inhalers in the U.S. that contain chlorofluorocarbon (CFC) propellants, because they destroy the Earth's ozone layer. These inhalers have been replaced with four distinct non-CFC propelled alternatives, which contain hydrofluoroalkane (HFA) propellant.

At a national press briefing held during the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), representatives from the organization and Allergy and Asthma Network Mothers of Asthmatics (AANMA) urged the medical community to educate their patients with respiratory disorders about the upcoming CFC-to-HFA transition.

"This is the first time that an effective medication has been removed from the market in the USA for an environmental issue," said Ira Finegold, MD, chief of the Division of Allergy and Clinical Immunology in the Department of Medicine at St. Luke's-Roosevelt Hospital in New York, and past president of the ACAAI. "However, the newer products available are not identical and each has specific differences. Physicians should monitor patients making the transition to HFA albuterol to be sure they understand the differences in the use and care of the newer products."

While the transition has been forthcoming for some time, data from IMS Health show that 14 million patients are still utilizing the older inhalers.(1) A medically responsible transition protocol assures patients are not unknowingly exposed to health risks beyond their control.

"A significant number of patients are still not aware of the federal mandate, or how to safely go about making this change," said Nancy Sander, presi
'/>"/>

SOURCE Allergy and Asthma Network/Mothers of Asthmatics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Council for Quality Respiratory Care Statement
2. Nations #1 Respiratory Hospital Enters Agreement to Co-Promote IgE Blood Testing
3. PARI Respiratory Releases Results of Study Comparing Nebulizers Delivering Budesonide at CHEST 2008
4. ILC Dover Introduces Patient Friendly Respiratory Protection for Health Care Market
5. PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza
6. PARI Respiratory Equipment Featured on Oxygen Network
7. Burning incense increases risk of respiratory tract cancers
8. Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics
9. National Jewish Named the #1 Respiratory Hospital for the Eleventh Year in a Row
10. Temple University Hospital Ranked Among Best in America for Respiratory Disorders by U.S. News & World Report
11. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...009) Wistar Institute researchers and collaborato...k University have identified immune system markers...rs in people at high risk for developing lung canc...Cancer Research , a journal of the American Associ...blood test to detect lung cancer in its earliest p...
(Date:12/1/2009)...MITHFIELD, R.I., Dec. 1 In the wo...ons are hazardous and can result in injury -- or w...on, a handful of persistent bad assumptions are wi... occupational Hearing Conservation Programs (HCPs...paper from Howard Leight, " Bad Assumptions abo...
(Date:12/1/2009)... Abrazo Media Relations-- The Cent...:// www.pedsorthopaedics.com ) located in Mesa, Ar...n Dr. J. Hunt Udall to its practice. ,, Dr. Ud...surgery after recently completing his fellowship t...etts where he focused on adult and pediatric ortho...
(Date:12/1/2009)...appiness declines with age are more likely to enga...g. Their misguided negative view of the aging proc... and encourage them to make the most of the presen...indings 1 by Dr. John Garry and Dr. Maria Lohan f...are published online in Springer,s Journal of Hap...
(Date:12/1/2009)...nsion announces general availability of its new En...d-to-end endpoint management capabilities on a sin...sole architecture. , Scot...a global leader in endpoint management and securit... Management and Security Suite (LEMSS) that will...
Breaking Medicine News(10 mins):Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:Binge drinking youths find getting old a drag 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
... survival for elderly patients with lung cancer ha...care expenditures for lung cancer treatment. The s...ute, and National Bureau of Economic Research rese... rose by less than one month between 1983 and 1997...
...odel of nonprofit fund-raising events and raises ... PHILADELPHIA, Oct. 20 Men and women from,across ...ked 10 miles,throughout Philadelphia today in the ...rts of the American Diabetes,Association. (Photo:...
...r Research, LLC, a pioneer in,the field of Busines...s,first-ever study on the Indian Contract Research...ort titled ,Indian Contract Research Industry, (CR...dia currently stands as one of the highest ranked ...
...ker Nancy Pelosi,issued the following statement to... Stark on the House floor during debate on the Sta...ay,s debate in the House to override the President...hat,Congressman Stark said during the debate was i...
... Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced t...pplement to a shelf registration statement with th... proposed public offering of,10,000,000 shares of ...shares of common stock to cover over-allotments, i...
...r-spurring gene goes to work, researchers say , F... they,ve identified a protein that could play a ke...According to a team at the Kimmel Cancer Center at...as. , However, pp32 is absent in the most aggressi...
Other Medicine News:Health News:Spending more for lung cancer treatment did not substantially increase patients' lives 2Health News:American Diabetes Association Steps Up to Fight Diabetes 2Health News:American Diabetes Association Steps Up to Fight Diabetes 3Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Arena Pharmaceuticals Announces Public Offering of Common Stock 2Health News:Protein Gives Clues to Pancreatic Cancer 2
(Date:12/1/2009)... CHENGDU, China, Dec. 1 /PRNewswire-Asia-First...mex: TPI ), a manufacturer and supplier of,modern... Chengdu, China, today,announced that it has recei...,Administration (SFDA) to produce Pediatric Fever ... (SFDA approval number Z20093060) and Antibacteria...
(Date:12/1/2009)...VILLE, Md., Dec. 1 Vanda...oday that the waiting period has expired under the...t of 1976 with respect to Vanda,s agreement, dated...at the agreement is now effective. Expiration of ...s of the agreement, triggers an upfront payment to...
(Date:12/1/2009)...DA, Md., Dec. 1 Micromet...ny developing novel, proprietary antibodies for th... diseases today announced that Bayer Schering Phar...ollaboration and license agreement entered into on...or the treatment of solid tumors. ,, Under the ...
Breaking Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Sensing disasters from space 10483 1Sensing disasters from space 10483 2General anesthetics lead to learning disabilities in animal models 59954 1General anesthetics lead to learning disabilities in animal models 59954 2General anesthetics lead to learning disabilities in animal models 59954 3Flu shots not to be sneezed at 59952 1Flu shots not to be sneezed at 59952 2
...aboratory,s Technology Transfer Expertise to Suppo...K, March 30 Biomarkers have become increasingly i...od for risk assessment, early detection, testing n...better drugs once they are developed. As part of ... for Alzheimer,s and other diseases, BARC Central ...
...as now been studied in combination with the most c...10 mg, 20 mg) in patients with mixed dyslipidemia ...y showed that Abbott ,s TRILIPIX(R) (fenofibric a...rosuvastatin calcium met all of the study,s primar...rosuvastatin calcium 5 mg significantly improved H...
Other Medicine Technology:BARC Central Laboratory Joins Alzheimer's Association Research Roundtable 2BARC Central Laboratory Joins Alzheimer's Association Research Roundtable 3New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 2New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 3New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 4New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 5
...the pathologist to visualize the presence of Human...g on a choice of sample types: tissue, monolayer-b... HPV cocktails utilize proprietary probe formulati...to HPV genotypes 16, 18, 31, 33, 35, 39, 51, 52, 5...
Afinion AS100 Analyzer
ID - Candida albicans
AlbiQuick™
Medicine Products: